Table 3.
Median questioning scores and IQR over time by scenario
| Scenario | Visits 1–3 (%) | Visits 4–6 (%) | Visits 7–9 (%) | Overall (%) | Improvement over time* |
| Adult cough/cold (n=52) | 37 (IQR=25–67) | 58 (IQR=40–83) | 64 (IQR=50–83) | 58 (IQR=33–83) | Yes (P=0.003) |
| Adult pain (n=52) | 46 (IQR=21–86) | 57 (IQR=43–79) | 64 (IQR=50–100) | 57 (IQR=39–86) | Yes (P=0.008) |
| Allergic rhinitis (n=50) | 25 (IQR=0–72) | 31 (IQR=0–50) | 33 (IQR=0–50) | 28 (IQR=0–50) | No (P=0.929) |
| Asthma (n=54) | 30 (IQR=14–64) | 42 (IQR=31–72) | 62 (IQR=36–86) | 44 (IQR=25–72) | Yes (P=0.004) |
| Diarrhoea (n=51) | 44 (IQR=19–81) | 44 (IQR=28–73) | 44 (IQR=25–66) | 44 (IQR=25–70) | No (P=0.707) |
| Dyspepsia (n=53) | 50 (IQR=25–81) | 75 (IQR=21–81) | 75 (IQR=13–89) | 63 (IQR=22–81) | No (P=0.198) |
| Insomnia (n=53) | 44 (IQR=25–63) | 69 (IQR=50–81) | 56 (IQR=25–78) | 56 (IQR=33–78) | No (P=0.274) |
| Paediatric cough/cold (n=54) | 22 (IQR=14–50) | 28 (IQR=25–50) | 38 (IQR=25–50) | 30 (IQR=19–50) | No (P=0.227) |
| Paediatric fever (n=51) | 11 (IQR=11–22) | 39 (IQR=17–56) | 44 (IQR=25–72) | 22 (IQR=11–56) | Yes (P=0.002) |
| Smoking cessation (n=51) | 44 (IQR=22–83) | 53 (IQR=25–69) | 58 (IQR=28–94) | 56 (IQR=22–78) | No (P=0.290) |
| All (n=521) | 38 (IQR=14–64) | 50 (IQR=25–72) | 50 (IQR=26–76) | 44 (IQR=22–75) | Yes (P<0.001) |
*Significance determined by Spearman’s rank order correlations, P<0.05.